March 2022
1. ELHEFNAWI M, Jo E, Tolba MM, Fares M, et al
   Drug repurposing through virtual screening and in vitro validation identifies tigecycline as a novel putative HCV polymerase inhibitor.
   Virology. 2022;570:9-17.
   

   >> Share

   
   September 2021
2. KIM MI, Pham TK, Kim D, Park M, et al
   Identification of brevinin-1EMa-derived stapled peptides as broad-spectrum virus entry blockers.
   Virology. 2021;561:6-16.
   

   >> Share

   
   February 2021
3. KANG X, Chen X, He Y, Guo D, et al
   Corrigendum to "DDB1 is a cellular substrate of NS3/4A protease and required for hepatitis C virus replication" [Virology 435 (2013) 385-394].
   Virology. 2021 Feb 8. pii: S0042-6822(21)00021.
   

   >> Share

   
   June 2020
4. LAFONTAINE E, Miller CM, Permaul N, Martin ET, et al
   Ribosomal protein RACK1 enhances translation of poliovirus and other viral IRESs.
   Virology. 2020;545:53-62.
   

   >> Share

   
   October 2019
5. FORBERG K, Rodgers MA, Dawson GJ, Sauleda S, et al
   Human pegivirus 2 exhibits minimal geographic and temporal genetic diversity.
   Virology. 2019;539:69-79.
   

   >> Share

   
   September 2019
6. MEJER N, Galli A, Ramirez S, Fahnoe U, et al
   Ribavirin inhibition of cell-culture infectious hepatitis C genotype 1-3 viruses is strain-dependent.
   Virology. 2019;540:132-140.
   

   >> Share

   
   July 2019
7. LU G, Ou J, Sun Y, Wu L, et al
   Natural recombination of equine hepacivirus subtype 1 within the NS5A and NS5B genes.
   Virology. 2019;533:93-98.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share